These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 35881885)

  • 1. Addressing stimulant use disorder through state opioid response grants from the substance abuse and mental health services administration: Missouri's initial approach.
    Winograd RP; Weinstock J; Ruiz A; Coffey B; Brown K; Kondai R; Connors E; Smith C
    Am J Drug Alcohol Abuse; 2022 Nov; 48(6):644-650. PubMed ID: 35881885
    [No Abstract]   [Full Text] [Related]  

  • 2. Implementation and evaluation of Missouri's Medication First treatment approach for opioid use disorder in publicly-funded substance use treatment programs.
    Winograd RP; Wood CA; Stringfellow EJ; Presnall N; Duello A; Horn P; Rudder T
    J Subst Abuse Treat; 2020 Jan; 108():55-64. PubMed ID: 31277891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Missouri's Fentanyl Problem: The China Connection.
    Stoecker WV; Bosworth KT; Rottnek F
    Mo Med; 2020; 117(4):362-369. PubMed ID: 32848274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expanding access to treatment for stimulant use disorder in a frontier state: A qualitative study of contingency management and TRUST program implementation in Montana.
    Green B; Parent S; Ware J; Hasson AL; McDonell M; Nauts T; Collins M; Kim F; Rawson R
    J Subst Use Addict Treat; 2023 Aug; 151():209032. PubMed ID: 37061191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Signals of increasing co-use of stimulants and opioids from online drug forum data.
    Sarker A; Al-Garadi MA; Ge Y; Nataraj N; Jones CM; Sumner SA
    Harm Reduct J; 2022 May; 19(1):51. PubMed ID: 35614501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pilot study assessing client understanding and use of fentanyl test strips for harm reduction.
    Barrolle AA; Gable KN; Dell N
    J Am Pharm Assoc (2003); 2023; 63(1):295-300. PubMed ID: 36280433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promoting sustainable responses to the US opioid epidemic with community-academic partnerships: qualitative outcomes from a statewide program.
    Driscoll DL; Cuellar AE; Agarwal V; Jones D; Dunkenberger MB; Hosig K
    Subst Abuse Treat Prev Policy; 2022 Apr; 17(1):26. PubMed ID: 35392939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stimulant safe supply: a potential opportunity to respond to the overdose epidemic.
    Fleming T; Barker A; Ivsins A; Vakharia S; McNeil R
    Harm Reduct J; 2020 Jan; 17(1):6. PubMed ID: 31924209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using social network analysis to understand Missouri's system of public health emergency planners.
    Harris JK; Clements B
    Public Health Rep; 2007; 122(4):488-98. PubMed ID: 17639652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "I probably got a minute": Perceptions of fentanyl test strip use among people who use stimulants.
    Reed MK; Roth AM; Tabb LP; Groves AK; Lankenau SE
    Int J Drug Policy; 2021 Jun; 92():103147. PubMed ID: 33583679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Part II: Missouri's Fentanyl Poisonings Rise to Record Levels.
    Stoecker WV; Smith CL; Connors E
    Mo Med; 2023; 120(1):10-14. PubMed ID: 36860612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of lower-cost incentives on stimulant abstinence in methadone maintenance treatment: a National Drug Abuse Treatment Clinical Trials Network study.
    Peirce JM; Petry NM; Stitzer ML; Blaine J; Kellogg S; Satterfield F; Schwartz M; Krasnansky J; Pencer E; Silva-Vazquez L; Kirby KC; Royer-Malvestuto C; Roll JM; Cohen A; Copersino ML; Kolodner K; Li R
    Arch Gen Psychiatry; 2006 Feb; 63(2):201-8. PubMed ID: 16461864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. U.S. Cooperative Extension's response to substance misuse: A scoping review.
    Hagaman A; Roark K; Washburn LT
    Front Public Health; 2023; 11():1127813. PubMed ID: 36875395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulant use among patients in opioid treatment settings: Provider perspectives.
    Breland H; Larkins S; Antonini V; Freese T; McGovern M; Dunn J; Rawson R
    J Subst Use Addict Treat; 2023 Aug; 151():209012. PubMed ID: 36931604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. State targeted response to the opioid Crisis grants (opioid STR) program: Preliminary findings from two case studies and the national cross-site evaluation.
    High PM; Marks K; Robbins V; Winograd R; Manocchio T; Clarke T; Wood C; Stringer M
    J Subst Abuse Treat; 2020 Jan; 108():48-54. PubMed ID: 31303359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Family planning funding through four federal-state programs, FY 1997.
    Gold RB; Sonfield A
    Fam Plann Perspect; 1999; 31(4):176-81. PubMed ID: 10435216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Care-engaged individuals with polysubstance use in Northeastern US are undertreated for methamphetamine use disorder: a retrospective cohort study.
    Yen Li M; Alba GA; Mitton J; Bearnot B
    Addict Sci Clin Pract; 2021 Sep; 16(1):57. PubMed ID: 34565489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Massachusetts Department of Public Health Post Overdose Support Team Initiative: A Public Health-Centered Co-Response Model for Post-Overdose Outreach.
    Formica SW; Reilly B; Duska M; Ruiz SC; Lagasse P; Wheeler M; Delaney A; Walley AY
    J Public Health Manag Pract; 2022 Nov-Dec 01; 28(Suppl 6):S311-S319. PubMed ID: 36194799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The case for a medication first approach to the treatment of opioid use disorder.
    Winograd RP; Presnall N; Stringfellow E; Wood C; Horn P; Duello A; Green L; Rudder T
    Am J Drug Alcohol Abuse; 2019; 45(4):333-340. PubMed ID: 31084515
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.